Yoshitsugu Aoki (Yasuko Asahina)

Researcher Name Resolver ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Communications biology

Scientific reports

International journal of molecular sciences

The Journal of pathology

National Center of Neurology and Psychiatry (NCNP)

Tokyo Medical and Dental University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Center of Neurology and Psychiatry (NCNP) Sep 01 2019

Japan

DIRECTOR :: Department of Molecular Therapy, National Institute of Neuroscience

Education History

Tokyo Medical and Dental University Apr 01 2007 - Mar 31 2011

Japan

PHD :: Graduate School of Medical and Dental Sciences

Publications

Masayoshi Otake, Michihiro Imamura, Satoko Enya, Akihisa Kangawa, Masatoshi Shibata, Kinuyo Ozaki, Koichi Kimura, Etsuro Ono, Yoshitsugu Aoki
Severe cardiac and skeletal manifestations in DMD-edited microminipigs: an advanced surrogate for Duchenne muscular dystrophy. Communications biology 7 (1) (2024)
Masayoshi Otake, Michihiro Imamura, Satoko Enya, Akihisa Kangawa, Masatoshi Shibata, Kinuyo Ozaki, Koichi Kimura, Etsuro Ono, Yoshitsugu Aoki
Severe cardiac and skeletal manifestations in DMD-edited microminipigs: an advanced surrogate for Duchenne muscular dystrophy. Communications biology 7 (1) (2024)
Masayoshi Otake, Michihiro Imamura, Satoko Enya, Akihisa Kangawa, Masatoshi Shibata, Kinuyo Ozaki, Koichi Kimura, Etsuro Ono, Yoshitsugu Aoki
Severe cardiac and skeletal manifestations in DMD-edited microminipigs: an advanced surrogate for Duchenne muscular dystrophy. Communications biology 7 (1) (2024)
Masayoshi Otake, Michihiro Imamura, Satoko Enya, Akihisa Kangawa, Masatoshi Shibata, Kinuyo Ozaki, Koichi Kimura, Etsuro Ono, Yoshitsugu Aoki
Severe cardiac and skeletal manifestations in DMD-edited microminipigs: an advanced surrogate for Duchenne muscular dystrophy. Communications biology 7 (1) (2024)
Takami Ishizuka, Hirofumi Komaki, Yoshitsugu Aoki, Harumasa Nakamura, Norio Motohashi, Eri Takeshita, Yuko Shimizu-Motohashi, Akihiko Ishiyama, Chihiro Yonee, Shinsuke Maruyama, Eisuke Hida, Yoshitsugu Aoki
Systemic administration of the antisense oligonucleotide NS-089/NCNP-02 for skipping of exon 44 in patients with Duchenne muscular dystrophy: Study protocol for a phase I/II clinical trial. Neuropsychopharmacology reports 43 (2) (2023)
Tsukasa Tominari, Masaru Takatoya, Toshiya Matsubara, Michio Matsunobe, Daichi Arai, Chiho Matsumoto, Michiko Hirata, Shosei Yoshinouchi, Chisato Miyaura, Yoshifumi Itoh, Hirofumi Komaki, Shin'ichi Takeda, Yoshitsugu Aoki, Masaki Inada
Establishment of a Triple Quadrupole HPLC-MS Quantitation Method for Dystrophin Protein in Mouse and Human Skeletal Muscle. International journal of molecular sciences 25 (1) (2023)
Tsukasa Tominari, Masaru Takatoya, Toshiya Matsubara, Michio Matsunobe, Daichi Arai, Chiho Matsumoto, Michiko Hirata, Shosei Yoshinouchi, Chisato Miyaura, Yoshifumi Itoh, Hirofumi Komaki, Shin'ichi Takeda, Yoshitsugu Aoki, Masaki Inada
Establishment of a Triple Quadrupole HPLC-MS Quantitation Method for Dystrophin Protein in Mouse and Human Skeletal Muscle. International journal of molecular sciences 25 (1) (2023)
Fusako Sakai-Takemura, Fumiaki Saito, Ken'ichiro Nogami, Yusuke Maruyama, Ahmed Elhussieny, Kiichiro Matsumura, Shin'ichi Takeda, Yoshitsugu Aoki, Yuko Miyagoe-Suzuki
Antioxidants restore store-operated Ca 2+ entry in patient-iPSC-derived myotubes with tubular aggregate myopathy-associated Ile484ArgfsX21 STIM1 mutation via upregulation of binding immunoglobulin protein. FASEB bioAdvances 5 (11) (2023)
Tsukasa Tominari, Masaru Takatoya, Toshiya Matsubara, Michio Matsunobe, Daichi Arai, Chiho Matsumoto, Michiko Hirata, Shosei Yoshinouchi, Chisato Miyaura, Yoshifumi Itoh, Hirofumi Komaki, Shin'ichi Takeda, Yoshitsugu Aoki, Masaki Inada
Establishment of a Triple Quadrupole HPLC-MS Quantitation Method for Dystrophin Protein in Mouse and Human Skeletal Muscle. International journal of molecular sciences 25 (1) (2023)
Nao Yamauchi, Katsuyuki Tamai, Iori Kimura, Azuma Naito, Nao Tokuda, Yuki Ashida, Norio Motohashi, Yoshitsugu Aoki, Takashi Yamada
High-intensity interval training in the form of isometric contraction improves fatigue resistance in dystrophin-deficient muscle. The Journal of physiology (2023)
Alex Zhu, Shuntaro Chiba, Yuki Shimizu, Katsuhiko Kunitake, Yasushi Okuno, Yoshitsugu Aoki, Toshifumi Yokota
Ensemble-Learning and Feature Selection Techniques for Enhanced Antisense Oligonucleotide Efficacy Prediction in Exon Skipping. Pharmaceutics 15 (7) (2023)
Yuki Ashida, Koichi Himori, Nao Tokuda, Azuma Naito, Nao Yamauchi, Nana Takenaka-Ninagawa, Yoshitsugu Aoki, Hidetoshi Sakurai, Takashi Yamada
Dissociation of SH3 and cysteine-rich domain 3 and junctophilin 1 from dihydropyridine receptor in dystrophin-deficient muscles. American journal of physiology. Cell physiology 323 (3) (2022)
Ryouhei Komaki, Yasumasa Hashimoto, Madoka Mori-Yoshimura, Yasushi Oya, Hotake Takizawa, Narihiro Minami, Ichizo Nishino, Yoshitsugu Aoki, Yuji Takahashi
Severe cardiac involvement with preserved truncated dystrophin expression in Becker muscular dystrophy by +1G>A DMD splice-site mutation: a case report. Journal of human genetics 65 (10) (2020)
Hotake Takizawa, Yuko Hara, Yoshitaka Mizobe, Taisuke Ohno, Sadafumi Suzuki, Ken Inoue, Eri Takeshita, Yuko Shimizu-Motohashi, Akihiko Ishiyama, Mikio Hoshino, Hirofumi Komaki, Shin'ichi Takeda, Yoshitsugu Aoki
Publisher Correction: Modelling Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-deazaneplanocin A hydrochloride. Scientific reports 10 (1) (2020)
Yuko Hara, Yoshitaka Mizobe, Yukiko U Inoue, Yasumasa Hashimoto, Norio Motohashi, Yoshiaki Masaki, Kohji Seio, Shin'ichi Takeda, Tetsuya Nagata, Matthew J A Wood, Takayoshi Inoue, Yoshitsugu Aoki
Novel EGFP reporter cell and mouse models for sensitive imaging and quantification of exon skipping. Scientific reports 10 (1) (2020)
Joel Z Nordin, Yoshitsugu Aoki
Autoimmune response and its long-term consequences after exon-skipping therapy in a Duchenne muscular dystrophy mouse model. The Journal of pathology 249 (3) (2019)
Hotake Takizawa, Yuko Hara, Yoshitaka Mizobe, Taisuke Ohno, Sadafumi Suzuki, Ken Inoue, Eri Takeshita, Yuko Shimizu-Motohashi, Akihiko Ishiyama, Mikio Hoshino, Hirofumi Komaki, Shin'ichi Takeda, Yoshitsugu Aoki
Modelling Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-deazaneplanocin A hydrochloride. Scientific reports 9 (1) (2019)

Yoshitsugu Aoki.css-eqlu8i{font-size:small;padding-left:4px;} (Yasuko Asahina)

Publication Activity (10 Years)

Top Topics

Top Venues

Yoshitsugu Aoki (Yasuko Asahina)